For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220325:nRSY1272Ga&default-theme=true
RNS Number : 1272G Rentokil Initial PLC 25 March 2022
Rentokil Initial plc (the Company)
The Company hereby announces that the awards granted under the Rentokil
Initial plc Performance Share Plan (PSP) in 2015, 2016, 2017 and 2018 to Paul
Cochrane (a person discharging managerial responsibility) have been exercised
with 366,020 shares subsequently sold on 25 March 2022 at a share price of
531.19p. Paul is retiring as Managing Director, Asia at Rentokil Initial at
the end of March.
The relevant notifications set out below are provided in accordance with the
requirements of Article 19 of the EU Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Paul Cochrane
2 Reason for the notification
a) Position/status Managing Director, Asia (PDMR)
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Rentokil Initial plc
b) LEI 549300VN4WV7Z6T14K68
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1p each
Identification code
ISIN: GB00B082RF11
b) Nature of the transaction Exercise of awards made under the Company's Performance Share Plan (PSP).
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil consideration 366,020
d) Aggregated information
- Aggregated volume 366,020 shares
- Price -
e) Date of the transaction 25 March 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
366,020 shares
-
e)
Date of the transaction
25 March 2022
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Paul Cochrane
2 Reason for the notification
a) Position/status Managing Director, Asia (PDMR)
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Rentokil Initial plc
b) LEI 549300VN4WV7Z6T14K68
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1p each
Identification code
ISIN: GB00B082RF11
b) Nature of the transaction Sale of shares.
c) Price(s) and volume(s)
Price(s) Volume(s)
£5.3119 366,020
d) Aggregated information
- Aggregated volume 366,020 shares
- Aggregated price £5.3119
- Total £1,944,261.64
e) Date of the transaction 25 March 2022
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information
- Aggregated volume
- Aggregated price
- Total
366,020 shares
£5.3119
£1,944,261.64
e)
Date of the transaction
25 March 2022
f)
Place of the transaction
London Stock Exchange (XLON)
Enquiries:
Catherine Stead, Deputy Company Secretary Rentokil Initial
plc 01293 858000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBLGDXCDDDGDU